CareLit Fachartikel

Predictive factors for the outcome of radioiodine therapy in patients with benign thyroid diseases

Florian Wedel, Thomas Exarchopoulos, Winfried Brenner · Nuklearmedizin - NuclearMedicine · 2024 · Heft 02 · S. 69-75

Dokument
896340
CareLit-ID
Jahr
2024
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Nuklearmedizin - NuclearMedicine
Autor:innen
Florian Wedel, Thomas Exarchopoulos, Winfried Brenner
Ausgabe
Heft 02 / 2024
Jahrgang 63
Seiten
69-75
Erschienen: 2024-04-01 00:00:00
ISSN
0029-5566
DOI
10.1055/a-2191-3113

Zusammenfassung

Abstract Purpose Radioiodine therapy (RIT) of benign thyroid diseases is an established therapy. This study aimed to identify factors predictive for outcome in patients with non-toxic goiter (NTG), unifocal (UFA), multifocal (MUFA) or diffuse autonomy (DISA) and Graves’ disease (GD). Methods Retrospective analysis of 205 patients with benign thyroid disease (54 NTG, 46 MUFA, 24 DISA, 26 UFA, 55 GD) who underwent RIT. Follow up time was 12 months for determining treatment outcome. Results The type of disease was predictive for volume reduction after 12 months (NTS 66%, DISA 67%, MUFA 58%, UFA 51%, GD 71%, p

Schlagworte

radioiodine therapy benign thyroid disease Graves’ disease nontoxic goiter unifocal autonomy multifocal autonomy Nuklearmedizin - NuclearMedicine